STOCK TITAN

[6-K] IM Cannabis Corp. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

IM Cannabis Corp. filed a Form 6-K reporting that it issued a press release dated October 23, 2025. The release states the company signed a non-binding term sheet to acquire a 60% stake in Innovative Quantum Computing Bio Data.

This filing signals a potential transaction at the term-sheet stage; terms and closing details are not included in the provided excerpt.

IM Cannabis Corp. ha presentato un Form 6-K comunicando di aver emesso un comunicato stampa datato 23 ottobre 2025. Il comunicato afferma che la società ha sottoscritto una term sheet non vincolante per acquisire una partecipazione del 60% in Innovative Quantum Computing Bio Data.

Questo deposito indica una potenziale operazione allo stato di term sheet; i termini e i dettagli di chiusura non sono inclusi nell'estratto fornito.

IM Cannabis Corp. presentó un Form 6-K informando que emitió un comunicado de prensa con fecha 23 de octubre de 2025. El comunicado indica que la empresa firmó un acuerdo marco no vinculante para adquirir una participación del 60% en Innovative Quantum Computing Bio Data.

Esta presentación señala una posible transacción en la etapa del acuerdo marco; los términos y los detalles de cierre no se incluyen en el extracto proporcionado.

IM Cannabis Corp.은 2025년 10월 23일자 보도자료를 발행했다는 내용을 담은 Form 6-K를 제출했다. 발표문은 회사가 구속력 없는 양해각서를 체결하여 Innovative Quantum Computing Bio Data60% 지분을 취득하기로 합의했다고 명시한다.

이 서류 제출은 양해각서 단계의 잠재적 거래를 시사하며; 용어 및 종결 세부사항은 제공된 발췌문에 포함되어 있지 않다.

IM Cannabis Corp. a déposé un Form 6-K indiquant qu'il a publié un communiqué de presse daté du 23 octobre 2025. Le communiqué indique que la société a signé une lettre d'intention non contraignante pour acquérir une participation de 60% dans Innovative Quantum Computing Bio Data.

Cette présentation signale une transaction potentielle au stade de la lettre d'intention ; les conditions et les détails de clôture ne figurent pas dans l'extrait fourni.

IM Cannabis Corp. hat ein Form 6-K eingereicht und berichtet, dass es eine Pressemitteilung vom 23. Oktober 2025 veröffentlicht hat. Die Mitteilung besagt, dass das Unternehmen eine unverbindliche Absichtserklärung unterzeichnet hat, um eine 60%-Beteiligung an Innovative Quantum Computing Bio Data zu erwerben.

Dieses Filing deutet auf eine potenzielle Transaktion im Stadium der Absichtserklärung hin; die Konditionen und Abschlussdetails sind im bereitgestellten Auszug nicht enthalten.

قدمت IM Cannabis Corp. نموذج Form 6-K مع رسالة تفيد بأن الشركة أصدرت بياناً صحفياً بتاريخ 23 أكتوبر 2025. ينص البيان على أن الشركة وقّعت ورقة شروط غير ملزمة للاستحواذ على حصة 60% في Innovative Quantum Computing Bio Data.

هذا الإيداع يشير إلى صفقة محتملة في مرحلة ورقة الشروط؛ لم تُدرج الشروط وتفاصيل الإغلاق في المقتطف المقدم.

IM Cannabis Corp. 已提交 Form 6-K,报告其发布的日期为 2025 年 10 月 23 日的新闻稿。新闻稿称公司已签署一份 非约束性意向书,以收购 Innovative Quantum Computing Bio Data60% 股权

该披露文件表明处于意向书阶段的潜在交易;条款及完成细节未包含在所提供的摘录中。

Positive
  • None.
Negative
  • None.

IM Cannabis Corp. ha presentato un Form 6-K comunicando di aver emesso un comunicato stampa datato 23 ottobre 2025. Il comunicato afferma che la società ha sottoscritto una term sheet non vincolante per acquisire una partecipazione del 60% in Innovative Quantum Computing Bio Data.

Questo deposito indica una potenziale operazione allo stato di term sheet; i termini e i dettagli di chiusura non sono inclusi nell'estratto fornito.

IM Cannabis Corp. presentó un Form 6-K informando que emitió un comunicado de prensa con fecha 23 de octubre de 2025. El comunicado indica que la empresa firmó un acuerdo marco no vinculante para adquirir una participación del 60% en Innovative Quantum Computing Bio Data.

Esta presentación señala una posible transacción en la etapa del acuerdo marco; los términos y los detalles de cierre no se incluyen en el extracto proporcionado.

IM Cannabis Corp.은 2025년 10월 23일자 보도자료를 발행했다는 내용을 담은 Form 6-K를 제출했다. 발표문은 회사가 구속력 없는 양해각서를 체결하여 Innovative Quantum Computing Bio Data60% 지분을 취득하기로 합의했다고 명시한다.

이 서류 제출은 양해각서 단계의 잠재적 거래를 시사하며; 용어 및 종결 세부사항은 제공된 발췌문에 포함되어 있지 않다.

IM Cannabis Corp. a déposé un Form 6-K indiquant qu'il a publié un communiqué de presse daté du 23 octobre 2025. Le communiqué indique que la société a signé une lettre d'intention non contraignante pour acquérir une participation de 60% dans Innovative Quantum Computing Bio Data.

Cette présentation signale une transaction potentielle au stade de la lettre d'intention ; les conditions et les détails de clôture ne figurent pas dans l'extrait fourni.

IM Cannabis Corp. hat ein Form 6-K eingereicht und berichtet, dass es eine Pressemitteilung vom 23. Oktober 2025 veröffentlicht hat. Die Mitteilung besagt, dass das Unternehmen eine unverbindliche Absichtserklärung unterzeichnet hat, um eine 60%-Beteiligung an Innovative Quantum Computing Bio Data zu erwerben.

Dieses Filing deutet auf eine potenzielle Transaktion im Stadium der Absichtserklärung hin; die Konditionen und Abschlussdetails sind im bereitgestellten Auszug nicht enthalten.


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of October 2025
 
Commission File Number: 001-40065

IM Cannabis Corp.
(Exact Name of Registrant as Specified in Charter)

Kibbutz Glil Yam, Central District, Israel 4690500
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒      Form 40-F
 

EXHIBIT INDEX
 
Exhibit No.
 
99.1
Press Release dated October 23, 2025 “IM Cannabis Signs Non-Binding Term Sheet to Acquire 60% Stake in Innovative Quantum Computing Bio Data”.
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
IM CANNABIS CORP.
 
 
(Registrant)
 
 
 
 
Date:  October 23, 2025

By:
/s/ Oren Shuster
 
 
Name:
Oren Shuster
 
 
Title:
Chief Executive Officer and Director


 

FAQ

What did IMCC report in its Form 6-K?

The company reported a press release stating it signed a non-binding term sheet to acquire a 60% stake in Innovative Quantum Computing Bio Data.

What is the date of the press release in IMCC’s 6-K?

The press release is dated October 23, 2025.

What ownership percentage is contemplated by the term sheet?

The term sheet contemplates acquiring a 60% stake.

What is the nature of the agreement disclosed by IMCC?

It is a non-binding term sheet, indicating a preliminary stage rather than a definitive agreement.

Which form did IM Cannabis file for this update?

IM Cannabis filed a Form 6-K as a foreign private issuer.
Im Cannabis Corp

NASDAQ:IMCC

IMCC Rankings

IMCC Latest News

IMCC Latest SEC Filings

IMCC Stock Data

10.28M
2.90M
44.66%
4.31%
0.15%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Tel Aviv